Register
Login:
Share:
Email Facebook Twitter


#AST: Board changes and new strategy for Ascent as Hutchinson looks at new projects
EXCLUSIVE: Petro Matad announce fully funded 4 well Mongolia campaign




Share Price Information for Shield Thera (STX)


Share Price: 36.40Bid: 35.40Ask: 37.40Change: 0.00 (0.00%)No Movement on Shield Thera
Spread: 2.00Spread as %: 5.65%Open: 36.40High: 36.40Low: 36.40Yesterday’s Close: 36.40

Shield Therapeutics Plc Ord 1.5P






Share Price SpacerPrice
36.40
Share Price SpacerBid
35.40
Share Price SpacerAsk
37.40
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
9,794
Share Price SpacerOpen
36.40
Share Price SpacerHigh
36.40
Share Price SpacerLow
36.40
Share Price SpacerClose
36.40
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 116.43m £42.38m 1,000

52 Week High 115.00 52 Week High Date 23-JAN-2018
52 Week Low 15.10 52 Week Low Date 1-MAY-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
3 9,794 0 -2.141 -17.00 0.00 0.00


London South East Users info for Shield Thera


Users who watch STX also watch: Victoria, Ferrexpo, Hochschild, Enquest, SolGold, Kaz Minerals, Evraz, Glencore

Users who hold STX also hold: Petards, Mirada, Challenger Aq, Tritax Big Box


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

18-Jan-19
16:14:29
35.40
5,000
Sell* 
35.40
37.40
1,770
Trade Type:
Ordinary

18-Jan-19
14:48:50
35.45
3,294
Sell* 
35.40
37.40
1,168
Trade Type:
Ordinary

18-Jan-19
14:09:47
35.91
1,500
Sell* 
35.40
37.40
538.65
Trade Type:
Ordinary




View more Shield Thera trades >>

Directors Deals for Shield Thera (STX)
Trade DateActionNotifierPriceCurrencyAmountHolding
21-Sep-18Buy
Trade Notifier Information for Shield Therapeutics
Carl Sterritt held the position of CEO at Shield Therapeutics at the time of this trade.
 Carl Sterritt
34GBX88,23510163496
04-Oct-17Exercise of option
Trade Notifier Information for Shield Therapeutics
Carl Sterritt held the position of CEO at Shield Therapeutics at the time of this trade.
 Carl Sterritt
100GBX8,81410075261
View more Shield Thera directors dealings >>


draft
Posts: 15,054
Opinion:No Opinion
Price:36.40
just waiting
Today 16:44
waiting
cf456
Posts: 446
Opinion:No Opinion
Price:36.40
Medical expert discusses Feraccru
Wed 16:07
Sharehodler
Posts: 7
Opinion:Strong Buy
Price:31.00
NDA date announced
17 Dec '18
So, the FDA has announced a target date for completion of the NDA review: July 27. Good news, as the FDA will have undertaken an initial review to decide whether to take the application forward. The PR suggests Shield is currently seeking a commercial partner in the US - presumably to coincide with approval and similar in structure to the Norgine deal in Europe, which gave the company an £11 million up-front plus €55m in sales and development milestones and 25-40% royalties on sales. A masterstroke given the situation at the time.

Now, from a position of relative strength and with the much bigger US market in Shield's sights, does anyone have any thoughts on how many times bigger any licensing deal done in the US would be than the Europe deal?
piworld
Posts: 139
Opinion:No Opinion
Price:31.00
STX at Mello November 2018
14 Dec '18
Here's the Shield Therapeutics presentation from Mello, November 2018.

https://www.piworld.co.uk/2018/12/14/shield-therapeutics-stx-presentation-at-mello-london-november-2018/

A good overview of what they do, by Tim Watts, CFO.

I was also interested to see they qualify for the Stockopedia R&D Breakthroughs Screen.
share_talk
Posts: 4,739
Opinion:No Opinion
Price:36.00
Share Talk - Twitter
12 Nov '18
@Share_Talk Bulletin Board Heroes, 12th Nov 2018 @ZaksTradersCafe Highlights

Anglo African #AAAP
Bushveld Minerals #BMN
Galantas Gold #GAL
N4 Pharma Plc #N4P
Oilex #OEX
Predator Oil #PRD
Polo Res #POL
Shield Thera #STX
W Resources #WRES

https://www.share-talk.com/share-talk-bulletin-board-heroes-monday-12th-november-2018/?utm_source=twitter&utm_medium=social&utm_campaign=SocialWarfare … via @share_talk

https://twitter.com/Share_Talk/status/1061942480399142912
View more share chat for Shield Thera (STX) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.